Revenue drop turns Indo US Bio-Tech loss-making in Q2FY27
Standalone revenue fell faster than expenses, driving a 29.29-point margin contraction and a Rs 3.67 cr net loss.
Filed 30 Oct 2026, 16:22 IST · after market close · Indo US Bio-Tech Ltd (INDOUS)
Key takeaways
- Revenue fell 54.38% sequentially to Rs 15.05 cr, while expenses declined only 39.20%, pushing operating margin down 29.29 percentage points.
- The company moved from a Rs 3.04 cr profit in Q1FY27 to a Rs 3.67 cr net loss in Q2FY27 as operating profit turned negative.
- Its -17.28% operating margin was 29.75 percentage points below the 12.47% median for 29 FMCG peers that had reported.
Price around the results
Revenue contraction erased operating profit
Indo US Bio-Tech reported standalone revenue of Rs 15.05 cr in Q2FY27, down 54.38% sequentially from Q1FY27. Expenses fell 39.20%, so the cost base did not adjust as quickly as revenue and operating profit swung from Rs 3.96 cr to a Rs 2.60 cr loss. The results were filed after market close on 30 October 2026.
Margin fell as costs outpaced revenue
Operating margin narrowed by 29.29 percentage points to -17.28% because expenses declined less than revenue. Interest expense also rose 9.46% sequentially to Rs 0.81 cr, adding pressure below operating profit. Other income was only Rs 0.05 cr and represented -1.37% of pre-tax profit, so it did not provide a meaningful offset.
Lowest margin among 29 reported FMCG peers
The standalone operating margin was 29.75 percentage points below the 12.47% median for the 29 FMCG peers that had reported the same quarter. This was a sharp reversal from Q1FY27, when the company had a 12.01% operating margin and Rs 3.04 cr of net profit. With no year-on-year comparison in the reported figures, the sequential deterioration is the clearest read on the quarter.
Q2FY27 at a glance
Standalone figures as filed with NSE — filed ahead of third-party databases, not yet independently cross-checked.
| Line item | Q2FY27 | Q1FY27 | QoQ |
|---|---|---|---|
| Revenue | ₹15 cr | ₹33 cr | -54.38% |
| Other income | ₹0 cr | ₹0 cr | -58.33% |
| Expenses | ₹18 cr | ₹29 cr | -39.20% |
| Operating profit | ₹-3 cr | ₹4 cr | — |
| Operating margin (%) | -17.28% | 12.01% | — |
| Interest | ₹1 cr | ₹1 cr | +9.46% |
| Depreciation | ₹0 cr | ₹0 cr | +3.70% |
| Profit before tax | ₹-4 cr | ₹3 cr | — |
| Tax | ₹0 cr | ₹0 cr | -50.00% |
| Net profit | ₹-4 cr | ₹3 cr | — |
| EPS (₹) | ₹-1.83 | ₹1.51 | — |
Operating margin of -17.28% compares with a Fast Moving Consumer Goods sector median of 12.47% across 29 peers that have reported Q2FY27.
What to watch
- Whether revenue recovers from Rs 15.05 cr in Q2FY27.
- Whether operating margin improves from -17.28% toward the Q1FY27 level of 12.01%.
- Whether interest expense eases from Rs 0.81 cr after rising 9.46% sequentially.